跳至主要内容
临床试验/NL-OMON54722
NL-OMON54722招募中不适用

Clinical phenotyping of postherpetic neuralgia patients to optimize pain treatment. - Clinical phenotyping of postherpetic neuralgia

niversitair Medisch Centrum Utrecht0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Aged 18 years or older.
  • - Diagnosed by a physicians with a herpes zoster skin rash.
  • - Pain in the dermatomes involved in the original eruption of herpes zoster.
  • - Able and willing to give written informed consent

排除标准

  • - Patients with previous neurolytic or neurosurgical treatment for PHN.
  • (Radiofrequency treatment of the DRG is allowed).
  • - Patients receiving pain treatment by topical capsaicin 8% in the last 6
  • - Patients who have other types of pain, which could confound the assessment of
  • the neuropathic pain due to PHN.
  • - Patients with polyneuropathy or severe other neurologic disease that might
  • affect outcome measures.
  • - Patients with skin conditions in the area affected by the neuralgia that
  • could alter sensation.
  • - Patients with major cognitive or psychiatric disorders.
  • - Problems with communication (language, deafness, aphasia etc.)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验